InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,573.60
(
-0.22%
)
Dow Jones
38,884.26
(
0.00%
)
Brent Oil
82.03
(
-1.01%
)
Bitcoin
62,415.88
(
0.13%
)
Post# of 458527
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

blu_1

Send PM Follow Ignore
Followers 23
Posts 911
Boards Moderated 0
Alias Born 10/22/2015

blu_1

Re: None

Sunday, 09/29/2019 11:43:40 AM

Sunday, September 29, 2019 11:43:40 AM

Post# of 458527
Has Anavex screened patients using precision medicine criteria before admitting them into the Alzheimers Ph2/3 trial? What I mean is, do enrollees have to possess the more favorable Sigma-1R and COMT genes? Is this true, or not, for the other ongoing Ph2 trials as well?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!